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Abstract
While thousands of large intergenic non-coding RNAs (lincRNAs) have been identified in 
mammals, few have been functionally characterized, leading to debate about their biological role. 
To address this, we performed loss-of-function studies on most lincRNAs expressed in mouse 
embryonic stem cells (ESC) and characterized the effects on gene expression. Here we show that 
knockdown of lincRNAs has major consequences on gene expression patterns, comparable to 
knockdown of well-known ESC regulators. Notably, lincRNAs primarily affect gene expression in 
trans. Knockdown of dozens of lincRNAs causes either exit from the pluripotent state or 
upregulation of lineage commitment programs. We integrate lincRNAs into the molecular 
circuitry of ESCs and show that lincRNA genes are regulated by key transcription factors and that 
lincRNA transcripts bind to multiple chromatin regulatory proteins to affect shared gene 
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expression programs. Together, the results demonstrate that lincRNAs have key roles in the 
circuitry controlling ESC state.
INTRODUCTION
The mammalian genome encodes many thousands of large non-coding transcripts1 including 
a class of ~3500 large intergenic ncRNAs (lincRNAs) identified using a chromatin signature 
of actively transcribed genes2–4. These lincRNA genes have been shown to have interesting 
properties, including clear evolutionary conservation2–5, expression patterns correlated with 
various cellular processes2,6 and binding of key transcription factors to their promoters2,6, 
and the lincRNAs themselves physically associate with chromatin regulatory proteins4,7. 
Yet, it remains unclear whether the RNA transcripts themselves have biological 
functions8–10. Few have been demonstrated to have phenotypic consequences by loss-of-
function experiments6. As a result, the functional role of lincRNA genes has been widely 
debated. Various proposals include that lincRNA genes act as enhancer regions, with the 
RNA transcript simply being an incidental by-product8,9, that lincRNA transcripts act in cis 
to activate transcription11, and that lincRNA transcripts can act in trans to repress 
transcription12,13.
We therefore sought to undertake systematic loss-of-function experiments on all lincRNAs 
known to be expressed in mouse embryonic stem cells (ESCs)2,3. ESCs are pluripotent cells 
that can self-renew in culture and can give rise to cells of any of the three primary germ 
layers including the germline14. The signalling14, transcriptional15–17, and chromatin15,18–21 
regulatory networks controlling pluripotency have been well characterized providing an 
ideal system to determine how lincRNAs may integrate into these processes.
Here we show that knockdown of the vast majority of ESC-expressed lincRNAs has a strong 
effect on gene expression patterns in ESCs, of comparable magnitude to that seen for the 
well-known ESC regulatory proteins. We identify dozens of lincRNAs that upon loss-of-
function cause an exit from the pluripotent state and dozens of additional lincRNAs that, 
while not essential for the maintenance of pluripotency, act to repress lineage-specific gene 
expression programs in ESCs. We integrate the lincRNAs into the molecular circuitry of 
ESCs by demonstrating that most lincRNAs are directly regulated by critical pluripotency-
associated transcription factors and ~30% of lincRNAs physically interact with specific 
chromatin regulatory proteins to affect gene expression. Together, these results demonstrate 
a regulatory network in ESCs whereby transcription factors directly regulate the expression 
of lincRNA genes, many of which can physically interact with chromatin proteins, affect 
gene expression programs, and maintain the ESC state.
RESULTS
lincRNAs affect global gene expression
To perform loss-of-function experiments, we generated five lentiviral-based short hairpin 
RNAs (shRNAs)22 targeting each of the 226 lincRNAs previously identified in ESCs2,3 (see 
Methods, Supplemental Table 1). These shRNAs successfully targeted 147 lincRNAs and 
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reduced their expression by an average of ~75% compared to endogenous levels in ESCs 
(see Methods, Figure 1a, Supplemental Figure 1, Supplemental Table 2). As positive 
controls, we generated shRNAs targeting ~50 genes encoding regulatory proteins, including 
both transcription and chromatin factors that have been shown to play critical roles in ESC 
regulation17,20,23; validated hairpins were obtained against 40 of these genes (Supplemental 
Table 2). As negative controls, we performed independent infections with lentiviruses 
containing 27 different shRNAs with no known cellular target RNA.
We infected each shRNA into ESCs, isolated RNA after 4 days, and profiled their effects on 
global transcription by hybridization to genome-wide microarrays (Figure 1a, see Methods). 
We employed a stringent procedure to control for non-specific effects due to viral infection, 
generic RNAi responses, or ‘off-target’ effects. Expression changes were deemed significant 
only if they exceeded the maximum levels observed in any of the negative controls, showed 
a two-fold change in expression compared to the negative controls, and had a low false 
discovery rate (FDR) assessed across all genes based on permutation tests (Figure 1b, see 
Methods). This approach controls for the overall rate of non-specific effects by estimating 
the number and magnitude of observed effects in the negative control hairpins, where all 
effects are non-specific.
For 137 of the 147 lincRNAs (93%), knockdown caused a significant impact on gene 
expression (Supplemental Table 3), with an average of 175 protein-coding transcripts 
affected (range: 20–936) (Figure 1c, Supplemental Figure 2, Supplemental Table 4). These 
results were similar to those obtained upon knockdown of the 40 well-studied ESC 
regulatory proteins: 38 (95%) showed significant effects on gene expression, with an 
average of 207 genes affected (range: 28 (for DNMT3L) to 1187 (for Oct4)) (Figure 1c, 
Supplemental Figure 2, Supplemental Table 4). Although some individual lincRNAs have 
been found to lead primarily to gene repression12,13, we find that knockdown of the 
lincRNAs studied here largely led to comparable numbers of activated and repressed genes 
(Supplemental Figure 2, Supplemental Table 4). To further assess ‘off-target’ effects, we 
also profiled the effects of the second-best validated shRNA targeting 10 randomly selected 
lincRNA genes. In all cases, second shRNAs against the same target produced significantly 
similar expression changes (see Methods, Supplemental Table 5). These results indicate that 
the vast majority of lincRNAs have functional consequences on overall gene expression of 
comparable magnitude (in terms of number of affected genes and impact on levels) to the 
known transcriptional regulators in ESCs.
lincRNAs affect gene expression in trans
Following the observation that a few lincRNAs act in cis 24,25, some recent papers have 
claimed that most lincRNAs act primarily in cis8,11,26. We found no evidence to support this 
latter notion: knockdown of only 2 lincRNAs showed effects on a neighbouring gene, only 
13 showed effects within a window of ten genes on either side, and only 8 showed effects on 
genes within 300 kb; these proportions are no greater than observed for protein-coding genes 
(Supplemental Figure 3, Supplemental Table 6). In short, lincRNAs appear to affect 
expression largely in trans.
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Our results contrast with a recent study that concluded that lincRNAs act in cis, based on the 
observation that knockdown of 7 out of 12 lincRNAs affected expression of a gene within 
300 kb11. The explanation appears to be that the threshold in the previous study failed to 
account for multiple hypothesis testing within the local region. Accounting for this, the 
effects on neighbouring genes are no greater than expected by chance and are consistent 
with our observations here (see Methods).
While some lincRNAs can regulate gene expression in cis11,24,25, determining the precise 
proportion of cis regulators requires more direct experimental approaches. We note that our 
results are consistent with observed correlations between lincRNAs and neighbouring 
genes2,26, which may represent shared upstream regulation2,12 or local transcriptional 
effects10,27. In addition, the lincRNAs studied here should be distinguished from transcripts 
that are produced at enhancer sites8,9, the function of which has yet to be determined.
lincRNAs maintain the pluripotent state
We next sought to investigate whether lincRNAs play a role in regulating the ESC state. 
Regulation of the ESC state involves two components, maintaining the pluripotency 
program and repressing differentiation programs15. To determine whether lincRNAs play a 
role in the maintenance of the pluripotency program, we studied their effects on the 
expression of Nanog, a key transcription factor that is required to establish28 and uniquely 
marks the pluripotent state29,30. We infected ESCs carrying a luciferase reporter gene 
expressed from the endogenous Nanog promoter31 with shRNAs targeting lincRNAs or 
protein-coding genes. We monitored loss of reporter activity after 8 days relative to 25 
negative control hairpins across biological replicates (see Methods). To ensure that the 
observed effects were not simply due to a reduction in cell viability, we excluded shRNAs 
that caused a reduction in cell numbers (see Methods, Supplemental Figure 4, Supplemental 
Table 7). Altogether, we identified 26 lincRNAs that had major effects on endogenous 
Nanog levels with many at comparable levels to the knockdown of the known protein-
coding regulators of pluripotency such as Oct4 and Nanog (Figure 2a, Supplemental Table 
7). This establishes that these lincRNAs have a role in maintaining the pluripotent state.
To further validate the role of these 26 lincRNAs in regulating the pluripotent state, we 
knocked down these lincRNAs in wild-type ESCs and measured mRNA levels of 
pluripotency marker genes Oct4, Sox2, Nanog, Klf4, and Zfp42 after 8 days. In all cases we 
observe a significant reduction in the expression of multiple pluripotency markers with 
>90% showing a significant decrease in both Oct4 and Nanog levels (Supplemental Figure 
5, Supplemental Tables 8,9). To control for ‘off-target’ effects, we studied additional 
hairpins targeting these lincRNAs. For 15 lincRNAs we had an effective second hairpin. In 
all 15 cases, the second hairpin produced comparable reductions in Oct4 expression levels, 
showing that the observations were not due to ‘off-target’ effects (Figure 2b, Supplemental 
Table 10). Notably, >90% of lincRNA knockdowns affecting Nanog reporter levels led to 
loss of ESC morphology (Figure 2c, Supplemental Figures 6, 7). Thus, inhibition of these 26 
lincRNAs lead to an increased exit from the pluripotent state.
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lincRNAs repress lineage programs
To determine if lincRNAs act in repressing differentiation programs we compared the 
overall gene expression patterns resulting from knockdown of the lincRNAs to published 
gene expression patterns resulting from induced differentiation of ESCs32,33 and assessed 
significance using a permutation-derived FDR34 (see Methods). These states include 
differentiation into endoderm, ectoderm, neuroectoderm, mesoderm, and trophectoderm 
lineages. As a positive control for our analytical method, we confirmed the expected results 
that the expression pattern caused by Oct4 knockdown was strongly associated with the 
trophoectoderm lineage35 and the pattern caused by Nanog knockdown was strongly 
associated with endoderm differentiation30 (Figure 3a).
Using this approach, we identified 30 lincRNAs whose knockdown produced expression 
patterns similar to differentiation into specific lineages (Supplemental Table 11). Amongst 
these lincRNAs, 13 are associated with endoderm differentiation, 7 with ectoderm 
differentiation, 5 with neuroectoderm differentiation, 7 with mesoderm differentiation, and 2 
with the trophectoderm lineage (Figure 3a). Consistent with these functional assignments, 
we observe that the majority (>85%) of the 30 lincRNAs associated with specific 
differentiation lineages showed upregulation of the well-known marker genes for the 
identified states17,32 upon knockdown (such as Sox17 (endoderm), Fgf5 (ectoderm), Pax6 
(neuroectoderm), Brachyury (mesoderm), and Cdx2 (trophectoderm)) (Figure 3b, 
Supplemental Figures 8, 9, Supplemental Tables 12, 13).
The fact that knockdown of these 30 lincRNAs induces gene expression programs 
associated with specific early differentiation lineages suggests that these lincRNAs normally 
are a barrier to such differentiation. Interestingly, most of the lincRNA knockdowns (~85%) 
that induce gene expression patterns associated with these lineages did not cause the cells to 
differentiate as determined by Nanog reporter levels (Supplemental Table 7) and Oct4 
expression (Supplemental Figure 10). This is consistent with observations for several critical 
ESC chromatin regulators, such as the polycomb complex; loss-of-function of these 
regulators similarly induce lineage-specific markers without causing differentiation18,36,37.
Together, these data indicate that many lincRNAs play important roles in regulating the ESC 
state, including maintaining the pluripotent state and repressing specific differentiation 
lineages.
lincRNAs are direct targets of ESC TFs
Having demonstrated a functional role for lincRNAs in ESCs, we sought to integrate the 
lincRNAs into the molecular circuitry controlling the pluripotent state. First, we explored 
how lincRNA expression is regulated in ESCs. Toward this end, we utilized published 
genome-wide maps of 9 pluripotency-associated transcription factors (TFs)16,38 and 
determined whether they bind to the promoters of lincRNA genes. Of the 226 lincRNA 
promoters ~75% are bound by at least one of 9 pluripotency-associated TFs (including Oct4, 
Sox2, Nanog, cMyc, nMyc, Klf4, Zfx, Smad, and Tcf3) with a median of 3 factors bound to 
each promoter (Figure 4a, Supplemental Figure 11, Supplemental Table 14), comparable to 
the proportion reported for protein-coding genes16. Interestingly, the 3 core factors (Oct4, 
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Sox2, and Nanog) bind to the promoters of ~12% of all ESC lincRNAs and ~50% of 
lincRNAs involved in the regulation of the pluripotent state.
To determine if lincRNA expression is functionally regulated by the pluripotency-associated 
TFs, we used shRNAs to knock down the expression of 5 of the 9 pluripotency-associated 
TF genes for which we could obtain validated hairpins and profiled the resulting changes in 
lincRNA expression after 4 days. Upon knockdown of a TF, ~50% of lincRNAs genes 
whose promoters are bound by the TF exhibit expression changes (Figure 4a); this 
proportion is comparable to that seen for protein-coding genes whose promoters are bound 
by the TF (Supplemental Figure 12). The strong but imperfect correlation between TF-
binding and effect of TF-knockdown is consistent with previous observations39 and may 
reflect regulatory redundancy in the pluripotency network40. In addition, we profiled the 
knockdown of an additional 7 pluripotency-associated transcription factors (including Esrrb, 
Zfp42, and Stat3). Altogether, for ~60% of the ESC lincRNAs, we identified a significant 
downregulation upon knockdown of one of these 11 TFs (Figure 4b, Supplemental Table 
15).
After retinoic-acid-induced differentiation of ESCs, the ESC lincRNAs show temporal 
changes across the time course with ~75% showing a decrease in expression compared to 
untreated ESCs (Supplemental Figure 13, Supplemental Table 16). Notably, all of the 
lincRNAs shown to regulate pluripotency are down-regulated upon retinoic acid treatment 
(Supplemental Figure 13). Our results establish that lincRNAs are direct transcriptional 
targets of pluripotency-associated TFs and are dynamically expressed across differentiation. 
Collectively, these results demonstrate that lincRNAs are an important regulatory 
component within the ESC circuitry.
lincRNAs bind diverse chromatin proteins
To explore how lincRNAs carry out their regulatory roles, we studied whether lincRNAs 
physically associate with chromatin regulatory proteins in ESCs. We previously showed that 
many human lincRNAs can interact with the polycomb repressive complex4, a complex that 
plays a critical functional role in the regulation of ESCs18,19. To determine whether the ESC 
lincRNAs physically associate with the polycomb complex, we crosslinked RNA-protein 
complexes using formaldehyde, immunoprecipitated the complex using antibodies specific 
to both the Suz12 and Ezh2 components of Polycomb, and profiled the co-precipitated 
lincRNAs using a direct RNA quantification method41 (see Methods). We performed 
immunoprecipitation of the Polycomb complex across 5 biological replicates and 8 mock-
IgG controls, and we assessed significance using a permutation test (see Methods, 
Supplemental Figure 16). Altogether, we identified 24 lincRNAs (~10% of the ESC 
lincRNAs) that were strongly enriched for both Polycomb components (Figure 5b, 
Supplemental Table 17).
To determine if lincRNAs interact with additional chromatin proteins, we systematically 
analysed chromatin-modifying proteins that have been shown to play critical roles in 
ESCs18–21,42. Specifically, we screened antibodies against 28 chromatin complexes (see 
Methods, Supplemental Figure 14, Supplemental Table 18) and identified 11 additional 
chromatin complexes that are strongly and reproducibly associated with lincRNAs (see 
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Methods, Supplemental Figure 15, 16). These chromatin complexes are involved in 
‘reading’ (PRC1, Cbx1, and Cbx3), ‘writing’ (Tip60/P400, PRC2, Setd8, ESET, and 
Suv39h1), and ‘erasing’ (Jarid1b, Jarid1c, and HDAC1) histone modifications, as well as a 
chromatin-associated DNA binding protein (YY1) (Figure 5a). Altogether, we found that 74 
(~30%) of the ESC lincRNAs are associated with at least one of these 12 chromatin 
complexes (Figure 5b, Supplemental Table 17). While most of the identified interactions are 
with repressive chromatin regulators, this is likely due to limitations of our selection criteria 
and available antibodies.
Many lincRNAs are strongly associated with multiple chromatin complexes (Figure 5b). For 
example, we identified 8 lincRNAs that bind to the PRC2 H3K27 and ESET H3K9 
methyltransferase complexes (‘writers’ of repressive marks) and the Jarid1c H3K4 
demethylase complex (an ‘eraser’ of activating marks). Consistent with this, the PRC2 and 
ESET complexes have been reported to bind at many of the same ‘bivalent’ domains21 and 
to functionally associate with the Jarid1c complex43. Similarly, we identified a distinct set of 
17 lincRNAs that bind to the PRC2 complex (‘writer’ of K27 repressive marks), PRC1 
complex (‘reader’ of K27 repressive marks), and Jarid1b complex (‘eraser’ of K4 activating 
marks) (Figure 5b), as well as other functionally consistent ‘reader’, ‘writer’, and ‘eraser’ 
combinations (Supplemental Figure 17). One of several potential models consistent with this 
data is that lincRNAs may bind to multiple distinct protein complexes, perhaps serving as 
‘flexible scaffolds’ to bridge functionally related complexes as previously described for 
telomerase RNA44.
To determine if the identified lincRNA-protein interactions have a functional role, we 
examined the effects on gene expression resulting from knockdown of individual lincRNAs 
that are physically associated with particular chromatin complexes and from knockdown of 
genes encoding the associated complex itself (see Methods). For >40% of these lincRNA-
protein interactions, we identified a highly significant overlap in affected gene expression 
programs compared to just ~6% for random lincRNA-protein pairs (see Methods, 
Supplemental Table 19). Other cases may reflect the limited power to detect the overlaps, 
because specific lincRNA-protein complexes may be related to only a fraction of the overall 
expression pattern mediated by the chromatin complex.
Together, these data demonstrate that many ESC lincRNAs physically associate with 
multiple different chromatin regulatory proteins and these interactions are likely to be 
important for the regulation of gene expression programs.
DISCUSSION
While the mammalian genome encodes thousands of lincRNA genes, few have been 
functionally characterized. We performed an unbiased loss-of-function analysis of lincRNAs 
expressed in ESCs and show that lincRNAs are clearly functional and primarily act in trans 
to affect global gene expression. We establish that lincRNAs are key components of the 
ESC transcriptional network that are functionally important for maintaining the pluripotent 
state, and that many are down-regulated upon differentiation. The ESC lincRNAs physically 
interact with chromatin proteins, many of which have been previously implicated in the 
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maintenance of the pluripotent state18,20,21. In addition to chromatin proteins, lincRNAs 
interact with other protein complexes including many RNA-binding proteins (data not 
shown).
Our data suggest a model whereby a distinct set of lincRNAs is transcribed in a given cell 
type and interacts with ubiquitous regulatory protein complexes to form cell-type-specific 
RNA-protein complexes that coordinate cell-type specific gene expression programs (Figure 
6). Because many of the lincRNAs studied here interact with multiple different protein 
complexes, they may act as cell-type specific ‘flexible scaffolds’44 to bring together protein 
complexes into larger functional units (Figure 6). This model has been previously 
demonstrated for the yeast telomerase RNA44 and suggested for the XIST45 and HOTAIR46 
lincRNAs. The hypothesis that lincRNAs serve as flexible scaffolds could explain the 
uneven patterns of evolutionary conservation seen across the length of lincRNA genes3: the 
more highly conserved patches could correspond to regions of interaction with protein 
complexes.
While a model of lincRNAs acting as ‘flexible scaffolds’ is attractive, it is far from proven. 
Testing the hypothesis for lincRNAs will require systematic studies, including defining all 
protein-complexes with which lincRNAs interact, determining where these protein 
interactions assemble on RNA, and ascertaining whether they bind simultaneously or 
alternatively. Moreover, understanding how lincRNA-protein interactions give rise to 
specific patterns of gene expression will require determination of the functional contribution 
of each interaction and possible localization of the complex to its genomic targets.
Methods Summary
RNAi expression affects—We cloned 5 shRNAs targeting each lincRNA into a 
puromycin-resistant lentiviral vector22. ESCs were plated on pre-gelatinized 96-well plates 
and infected with lentivirus prior to addition of irradiated DR4 MEFs. Media containing 
1ug/mL puromycin was added 24 hr after infection. On-target knockdown was assessed after 
4 days and the best hairpin showing a knockdown >60% was selected. RNA from 147 
lincRNAs, 40 protein-coding genes, and 27 negative controls were hybridized to Agilent 
microarrays. Differentially expressed genes were defined as having an FDR<5% and fold-
change >2-fold compared to controls.
Screening for pluripotency affects—Nanog-Luciferase ESCs31 were infected and 
measured after 8 days. Hits were identified if they reduced luciferase levels (z<−6) across all 
replicates and did not reduce AlamarBlue levels. Hits were validated in wild-type ESCs by 
measuring mRNA levels of Oct4, Nanog, Sox2, Klf4, and Zfp42. Oct4 expression was 
assessed using immunofluorescence staining and morphology was visually assessed.
Lineage expression affects—Lineage expression programs were defined using 
published datasets (GSE12982, GSE11523, and GSE4082) and curated gene expression 
signatures32,33. Overlaps in gene expression affects were assessed using a modified 
GSEA34. Expression changes in lineage markers were determined using qPCR.
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TF binding and regulation—ChIP-Seq data was downloaded (GSE11724 and 
GSE11431), aligned, and analysed. lincRNA promoters were previously defined using 
H3K4me3 peaks3. Changes in expression of the lincRNAs upon knockdown of the TFs were 
analyzed using Agilent microarrays.
Chromatin binding and overlap in expression—ESCs were crosslinked with 
formaldehyde, lysed, immunoprecipitated, washed, and reverse crosslinked. RNA was 
hybridized to the Nanostring codeset. We tested antibodies for 28 chromatin complexes and 
selected successful antibodies that (i) had >10 lincRNAs exceeding a 5-fold change and (ii) 
had significant enrichments across 3 replicates. We compared the overlap in gene expression 
using a modified GSEA34.
METHODS
ES Cell Culture
V6.5 (genotype 129SvJae × C57BL/6) and Nanog-Luciferase31 ES cells were co-cultured 
with irradiated C57BL/6 MEFs (GlobalStem; GSC-6002C) on pre-gelatinized plates as 
previously described47. Briefly, cells were cultured in mES media consisting of knock-out 
DMEM (Invitrogen; 10829018) supplemented with 10% FBS (GlobalStem; GSM-6002), 
1% penicillin-streptomycin (Invitrogen; 15140-163), 1% L-glutamine (Invitrogen; 
25030-164), 0.001% Beta-mercaptoethanol (Sigma; M3148-100ML) and 0.01% ESGRO 
(Millipore; ESG1106).
Picking lincRNA gene candidates
Using our previous catalogue of K4-K36 defined lincRNAs2 along with the reconstructed 
full-length sequences we determined using RNA-Seq3, we designed shRNA hairpins 
targeting each lincRNA identified in both sets. Specifically, we used the conservative K4-
K36 definitions from our previous work2 that were expressed in mouse ES cells. We further 
filtered the list to include only multi-exonic lincRNAs that were reconstructed in mouse ES 
cells3. Together, this yielded 226 lincRNA genes.
Picking protein-coding gene candidates
We selected protein coding gene controls consisting of both transcription factors and 
chromatin proteins. These proteins were selected based on their well-characterized role in 
regulating mouse ES cells and include Pou5f1 (Oct4)35,48, Sox217,49, Nanog29,30, Stat350, 
Klf451, and Zfp42 (Rex1)52. In addition, we selected additional transcriptional and 
chromatin regulators that were identified by RNAi screens as regulators of 
pluripotency17,20,23 and/or were found in smaller focused studies to have critical roles in the 
maintenance of the pluripotent state (such as Carm153, Chd154, Thap1155, Suz1218,19,36, and 
Setdb121,56). A full list is provided in Supplemental Table 2.
shRNA Design Rules
For each lincRNA we designed 5 hairpins by extending the previously described design 
rules22 accounting for the sequence content of the hairpin, miRNA seed matches, uniqueness 
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to the target compared to the transcriptome and the genome, and number of lincRNA 
isoforms covered.
For each lincRNA we enumerated all 21-mer sub-sequences and scored them as follows: (i) 
A “clamp score” was computed by looking at the nucleotides at positions 18, 19, and 20. If 
all three positions contained an A/T it was assigned a score of 4, if two positions were A/T it 
was assigned a score of 1.5 and if one was A/T it was assigned a score of 0.8. We then 
looked at positions 16, 17, and 21 if all 3 were A/T it was assigned a score of 1.25, if 2 were 
A/T it was assigned a score of 1.1, and if 1 was A/T is was assigned a score of 0.8. The 
clamp score was computed as the product of these two scores. (ii) A “GC score” was 
computed by looking at the total GC percentage of the 21-mer sequence. If the sequence was 
<25% GC it was assigned a score of 0.01 if it was <55% it was assigned a score of 3, if it 
was <60% it was assigned a score of 1, and if >60% it was assigned a score of 0.01. (iii) A 
“4-mer penalty” of 0.01 was assigned for any hairpin containing the same nucleotide in 4 
subsequent nucleotides. (iv) A “7 GC penalty” of 0.01 was assigned to any hairpin 
containing any 7 consecutive G/C nucleotides. (v) We removed all hairpins containing an A 
in either position 1 or position 2 of the hairpin. (vi) We removed all hairpins containing a 
repeat masked nucleotide. (vii) Finally, we computed a “miRNA-seed penalty” by looking at 
the forward positions 11–17, 12–20, and 13–19 of the hairpin as well as the reverse 
complement of positions 14–20, 15–21, or 16–21 plus a 3′ C. We then looked up whether 
these positions matched known miRNA seeds and with what frequency. We computed the 
scores for the forward and reverse positions and defined the score as the product of the 
forward and reverse scores. The final score for each hairpin sequence is defined as the 
product of all seven scores.
We then sorted the candidate hairpin sequences by score, breaking high scoring ties by the 
total number of lincRNA isoforms that are covered by the hairpin. We then aligned each 
hairpin sequence against both the genome and the RefSeq-defined transcriptome (NCBI 
Release 39), and filtered any hairpin with fewer than three mismatches to any other gene or 
position in the genome. Candidate sequences were chosen for shRNA production by first 
picking the highest scoring candidate and then proceeding to successively lower scores. As 
each hairpin was selected, all other hairpins overlapping this hairpin were removed. We 
repeated this process until we identified 5 hairpins that covered each lincRNA.
shRNA cloning and virus prep
We designed 1,143 hairpins targeting 226 lincRNA genes. Of these, we successfully cloned 
1,010 hairpins targeting 214 lincRNAs. These hairpins were cloned into a vector containing 
a puromycin resistance gene and incorporated into a lentiviral vector as previously 
described22. Briefly, synthetic double stranded oligos that represent a stem-loop hairpin 
structure were cloned into the second-generation TRC (the RNAi Consortium) lentiviral 
vector, pLKO.5; the expression of a given hairpin produces a shRNA that targets the gene of 
interest. Lentivirus was prepared as previously described22. Briefly, 100ng of shRNA 
plasmid, 100ng of packaging plasmid (psPAX2) and 10ng of envelope plasmid (VSV-G) 
were used to transfect packaging cells (293T) with TransIT-LT1 (Mirus Bio). Virus was 
harvested 48 and 70 hours post-transfection. Two harvests were combined. Virus titers were 
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measured as previously described22. Briefly, we measured virus titers by infecting A549 
cells with appropriately diluted viruses. 24 hours post infection, puromycin was added to a 
final concentration of 5ug/ml and the selection proceeded for 48 hours. The number of 
surviving cells, which is correlated to virus titer, was measured by alamarBlue (BioSource) 
staining utilizing the Envision 2103 Multilabel plate reader (PerkinElmer)
Infection and selection protocol
V6.5 ESCs or Nanog-Luciferase ESCs were plated at a density of 5000 cells/well (8-day 
time point) or 25,000 cells/well (4-day time point) in 100ul mES media onto pre-gelatinized 
96-well dishes (VWR; BD356689). Cells were infected with 5ul of a lentiviral shRNA stock 
and incubated at 37°C for 30 minutes. Puromycin resistant DR4 MEFs (GlobalStem; 
GSC-6004G) were then added to the plates at a density of ~6000 cells/well and incubated 
overnight at 37°C, 5% CO2. After 24 hours, all media was removed from the cells and 
replaced with media containing 1ug/mL puromycin. Media was then changed every other 
day with fresh media containing 1ug/mL puromycin. The end-point depended on the assay 
and was either 4-days post infection (knockdown validation and microarrays) or 8-days 
(reporters and qPCR of marker genes).
RNA Extraction
ES cells were infected and lysed at day 4 with 150ul of Qiagen’s RLT buffer and 3 
replicates of each virus plate were pooled for RNA extraction using Qiagen’s RNeasy 96-
well columns (74181). RNA extraction was completed following Qiagen’s RNeasy 96-well 
protocol with the following modifications: 450ul of 70% ethanol was added to 450ul total 
lysate prior to the first spin. An additional RPE wash was added to the protocol, for a total of 
3 RPE washes.
lincRNA primer design and prescreen
lincRNA primers were designed using primer3 (http://frodo.wi.mit.edu/primer3/). 
Specifically, we designed primers spanning exon-exon junctions by specifying each of the 
regions as preferred inclusion regions in the primer3 program. When a low scoring primer 
pair (primer penalty <1) was available it was used. If none was available, we then identified 
all primers that contained amplicons that spanned an exon-exon junction. In a few cases, 
when we could not identify a primer pair spanning an exon-exon junction, we designed 
primers within an exon of the lincRNA. For each primer pair, we tested the specificity 
against the transcriptome57 (Ref Seq NCBI Release 39) and the genome (Mouse MM9) 
using the isPCR (http://genome.ucsc.edu/cgi-bin/hgPcr) program. Specifically, we required 
that the primer pair amplify the lincRNA gene and no other genomic of gene amplicon.
For each primer pair, we validated the quantification and specificity prior to use. 
Specifically, we tested primers in qPCR reactions using a dilution series of mouse ES cDNA 
including a no reverse transcriptase (RT) sample. We excluded any primer that did not have 
robust quantification across a 64-fold dilution curve, had high signal in the no RT sample, or 
had low detectable expression in the undiluted sample (cycle number >34). For primers that 
failed this validation we redesigned and tested new primers.
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Knockdown validation using qPCR
To determine if lincRNA hairpins were effective at knocking down the lincRNA of interest, 
we infected each hairpin into mouse embryonic stem cells, selected for lentiviral integration, 
and measured changes in the targeted lincRNA expression level. We isolated total cellular 
RNA after 4 days; this time-point was chosen to allow for identification of robust changes 
while minimizing secondary effects due to differentiation of the ES cells. We reasoned that 
this would allow us to determine more direct effects due to RNAi rather than to 
differentiation.
Gene panels were constructed that contained all 5 hairpins targeting a gene along with an 
empty vector control pLKO.5-nullT and the GFP-targeting hairpin clonetechGfp_437s1c1. 
cDNA was generated using 10ul of RNA and 10ul of 2x cDNA master mix containing 5x 
Transcriptor RT Reaction Buffer (Roche), DTT, MMLV-RT (Roche), dNTPs (Agilent; 
200415-51), Random 9-mer oligos (IDT), Oligo-dT (IDT) and water. cDNA was diluted 1:9 
and quantitative PCR was performed using 250 nM of each primer in 2x Sybr green master 
mix (Roche) and run on a Roche Light-Cycler 480. Target lincRNA expression and GAPDH 
levels were computed for each panel. lincRNA expression levels were normalized by 
GAPDH levels and this normalized value was compared to the reference control hairpins 
within the panel. Knockdown levels were computed as the average of the fold decrease 
compared to the two control hairpins. Hairpins showing a knockdown greater than 60% of 
the endogenous level were considered validated and the best validated hairpin from a 
lincRNA panel was selected for microarray studies.
Picking candidates for microarray analysis
To assess the effects of a lincRNA on gene expression, we profiled the changes in gene 
expression after knocking down each lincRNA gene. Specifically, for each lincRNA with at 
least 1 validated hairpin we profiled the genome-wide expression level changes after 
knockdown across 2 independent infections (see above). To control for expression changes 
due to viral infection, we performed five independent infections containing no RNAi hairpin 
(pLKO.5-nullT). This control hairpin was embedded in each RNA prep plate. To control for 
effects due to an off-target RNAi effect, we profiled 27 distinct negative control hairpins 
which do not have a known target in the cell. These hairpins included 6 RFP hairpins, 10 
GFP hairpins, 6 Luciferase hairpins, and 5 LacZ hairpins. These hairpins provide a 
measurement of the variability of the RNAi response triggered due to non-specific effects. 
Furthermore, we profiled hairpins targeting 147 lincRNAs, including 10 with a second best 
hairpin, and 40 protein-coding genes in biological replicate. The hairpins and their replicates 
were randomly distributed across 7 96-well plates and prepared in batches. Each RNA 
preparation batch contained 1 pLKO hairpin and 1 clonetechGfp_437s1c1 hairpin in a 
random location on the plate. To minimize batch effects, the plate locations of the biological 
replicates were scrambled and the positions within the plates were scrambled for all hairpins 
and replicates.
Agilent Microarray hybridization
Using Agilent’s One-Color Quick Amp Labelling kit (5190-0442), we amplified and 
labelled total RNA for hybridization to prototype mouse lincRNA arrays (G4140-90040) 
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according to manufacturer’s instructions with a few variations. The custom Agilent 
SurePrint G3 8×60K mouse array design used for this study (G4102A, AMADID 025725 
G4852A) has probes to 21,503 Entrez genes and 2,230 lincRNA genes. A new updated 
version of this mouse design is commercially available that contains probes to 34,017 Entrez 
gene targets as well as 2,230 lincRNA genes (G4825A). The cRNA samples were prepared 
by diluting 200ng of RNA in 8.3ul water and adding positive control one-color RNA spike-
in mix (Agilent, 5188-5282) that was diluted serially 1:20, then 1:25 and finally 1:10. We 
annealed the T7 promoter primer from the kit by incubating at 65°C for 10 minutes. We 
prepared the cDNA master mix and added it to the annealed RNA and incubated at 40°C for 
2 hours, followed by 65°C for 15 minutes. We prepared the cRNA transcription master mix 
and added it to the cDNA and incubated at 40°C for 2 hours protected from light. We 
purified the labeled cRNA using Qiagen’s RNeasy 96-well columns (Qiagen, 74181) by 
adding 350ul of Qiagen RLT (without BME) to the cRNA followed by the addition of 250ul 
of 95% ethanol before applying to the plate column. After a 4 minute spin at 6000RPM, we 
washed the columns 3 times with 800ul buffer RPE. We dried the columns by spinning for 
10 minutes and eluted the cRNA with 50ul of water. We measured the cRNA yield and dye 
incorporation using the Nanodrop 8000 Microarray measurement setting. We mixed 600ng 
of cRNA with blocking agent and fragmentation buffer (Agilent, 5190-0404) and 
fragmented for 30 minutes in the dark at 60°C. We added 2x Hybridization Buffer to each 
sample and loaded 40ul onto an 8-pack Hybridization gasket. We placed the microarray 
slides on top, sealed in the Hybridization Chamber, and incubated for 18 hours at 65°C. We 
washed the slides for 1 minute in room temperature GE Wash Buffer 1 and then for 1 minute 
in 37°C GE Wash Buffer 2 (Agilent 5188-5327, no triton addition). We scanned the 
microarrays using an Agilent Scanner C (G2565CA) using the following settings: Dye 
Channel = Red&Green, Scan Region = ScanArea (61×21.6mm), Scan Resolution = 3 μm. 
We prepared all of the samples simultaneously using homogenous master mixes to limit 
variability. Fragmentation and hybridization was staggered over time in batches of 3 to 4 
slides (24 to 32 samples).
Array filtering, Normalization, and Probe filtering
Each array was processed and data extracted using the Agilent feature extraction software 
(G4462AA, Version 10.7.3). Samples were retained if they passed all the following quality 
control statistics:
AnyColorPrcntFeatNonUnifOL<1,
eQCOneColorSpikeDetectionLimit >0.01 and <2.0,
Metric_absGE1E1aSlope between 0.9 and
Metric_gE1aMedCVProcSignal <8, 1.2,
gNegCtrlAveBGSubSig >−10 and <5,
Metric_gNegCtrlAveNetSig <40,
gNegCtrlSDevBGSubSig <10,
Metric_gNonCntrlMedCVProcSignal <8,
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Metric_gSpatialDetrendRMSFilterMinusFit <15,
SpotAnalysis_PixelSkewCookiePct >0.8 and <1.2
Gene expression values were determined using the gProcessedSignal intensity values. 
Probes were flagged if they were not detectable well above background or had an expression 
level lower than the lowest detectable spike-in control value. The values were floored across 
all samples by taking the maximum of the minimum non-flagged values across all 
experiments. Any value less than this maximum value were set to the maximum. This 
conservatively eliminates any detection variability across the samples due to stringency or 
other array variables.
The result of this is a single value for each probe per array. To normalize expression values 
across arrays, we performed quantile normalization as previously described58. Briefly, we 
ranked each array from lowest to highest expression. For each rank, we computed the 
average expression and each experiment with this value at the associated rank. For each 
probe, we computed the difference between the second smallest expression value and the 
second largest expression value. If this difference was less than 2, we filtered the probe. This 
metric was chosen to eliminate bias due to single sample outliers.
Identifying significant gene expression hits from RNAi KDs
To control for effects due to non-specific effects of shRNAs, we profiled 27 distinct 
negative control hairpins which do not have a known target in the cell. These hairpins 
provide a measurement of the variability of the expression profiles due to random variability 
or triggered by ‘off-target’ effects of the shRNA lentiviruses. Assuming that any observed 
effects in the negative control hairpins are due to ‘off-target’ effects and observed effects in 
the targeting hairpins include a mix of both ‘off-target’ effects and ‘on-target’ effects, we 
use permutations of the negative controls to assign a false discovery rate (FDR) confidence 
level for being an ‘on-target’ hit to each gene. As such, a gene would only reach genome-
wide significance if the number of genes and scale of the effect was much larger than would 
be observed randomly among all of the expression changes found for the negative control 
hairpin.
Specifically, for each gene we computed a t-statistic between shRNAs targeting the 
lincRNA and control shRNA samples. To assess the significance of each gene we permuted 
the sample and control groups retaining the relative sizes of the groups and computing the 
same t-statistic. We then assigned an FDR value to each gene by computing the average 
number of values in the permuted t-statistics that were greater than the observed value of 
interest and divided this by the number of all observed t-statistics that were greater than the 
observed value. We defined genes as significantly differentially expressed if the FDR was 
<5% and the fold-change compared to the negative controls was >2-fold. Using this 
approach, an effect would only reach a significant FDR if the scale is significantly larger 
than would be observed in the negative controls. Knockdown of a lincRNA was considered 
to have a significant effect of gene expression if we identified at least 10 genes that had an 
effect that passed all of the criteria.
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Gene-Neighbour analysis
We identified neighbouring genes based on the RefSeq genome annotation57 (NCBI Release 
39). We excluded from analysis all RefSeq genes that corresponded to our lincRNA of 
interest but included all other coding and non-coding transcripts. We identified a significant 
hit as any lincRNA affecting a neighbour within 10 genes on either side with an FDR<.05 
and 2-fold expression change. To compute the closest affected neighbour, we classified all 
genes affected upon knockdown of the lincRNAs using the same criteria above. We 
computed the distance between each affected gene and the locus of the lincRNA gene (and 
protein-coding gene) that was perturbed and took the minimum absolute distance across all 
affected genes.
Analysis of expected number of neighbouring genes that will change by chance
To determine the expected number of differentially expressed “neighbouring” genes 
occurring by chance assuming that the knockdown has no effect on gene expression, we 
calculated the average number of genes in a 300Kb window around a randomly selected 
gene in the human and mouse genome. We calculated this to be 11.2 (human) and 11.8 
(mouse). For simplicity, we will conservatively round this down to 11. Assuming that no 
genes are changing between the knockdown and control, using a nominal p-value, which has 
a uniform distribution under the null hypothesis (nothing effected), we would expect to see a 
difference called in 5% of cases at a p-value of 0.05. If we test one locus, which has on 
average 11 neighbours we would expect to identify 0.55 hits by chance (11 × 0.05=0.55). 
However, if we now test 12 loci we would expect to see 6.6 (12 × 0.55) knockdowns which 
appear to have an effect under the null hypothesis.
Luciferase analysis of Nanog ES lines
ES cells containing a Nanog-Luciferase construct31 were infected in biological duplicate and 
monitored after 7 days. Luciferase activity was measured using Bright-Glo (Promega). All 
reagents and cells were equilibrated to room temperature. 100ul Bright-Glo solution was 
added to each plate well. Plates were incubated in the dark at room temperature for 10 
minutes and luciferase was measured on a plate reader. The luciferase units were normalized 
to the control hairpins and a z-score compared to the negative controls (excluding luciferase 
hairpins) was computed. For each hairpin, we computed a Z-Score relative to the negative 
control hairpins and identified hits reducing Luciferase levels more than 6 standard 
deviations (Z<−6) for both independent replicates. In all cases we were able to identify a 
significant reduction in luciferase levels when using distinct hairpins targeting luciferase. To 
exclude hits that were due to an overall reduction in proliferation (which would also cause a 
reduction of Nanog positive cells in this read-out) we excluded all hairpins that caused a 
reduction in proliferation as measured by AlamarBlue incorporation (described below). 
AlamarBlue incorporation was measured in the same cells immediately before reading out 
Nanog-Luciferase levels.
AlamarBlue analysis of ES lines
After a 7 day infection, Nanog-Luciferase cell viability was measured using AlamarBlue 
(Invitrogen; DAL1025). AlamarBlue was mixed with mES media in a 1:10 ratio, added to 
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the cells and incubated at 37°C for 1 hour. Absorbance readings at 570nm were taken. To 
control for possible effects due to virus titer, we measured AlamarBlue incorporation on 
both puromycin treated and non-puromycin treated samples for each infection.
mRNA Analysis of pluripotency markers
V6.5 ESCs were infected with shRNAs targeting lincRNAs, protein-coding genes, and 21 
negative controls. After 8-days, RNA was extracted and mRNA levels of the Oct4, Nanog, 
Sox2, Klf4, and Zfp42 pluripotency markers were analysed using qPCR. Primer sequences 
are listed in Supplemental Table 9. Each sample was normalized to Gapdh levels. 
Significance was assessed compared to the negative control hairpins using a one-tailed t-test.
To control for ‘off-target’ effects, we analysed additional hairpins against the 26 lincRNAs 
affecting Nanog-Luciferase levels. Of the 26 lincRNAs, we identified 15 lincRNAs that 
contained an additional hairpin that reduced lincRNA expression by >50%. V6.5 ESCs were 
infected with the best and additional hairpin across biological replicates for these 15 
lincRNAs and 21 negative control hairpins. RNA was extracted after 8 days and Oct4 
expression levels were determined using qPCR. Significance was assessed relative to the 
negative controls using a one-tailed t-test.
Immunofluorescence
We crosslinked cells in 4% paraformaldehyde for 15 minutes, and washed in 1x PBS three 
times. To permeabilize the cells, we washed with 1x PBS + 0.1% Triton and then blocked in 
1x PBS + 0.1% Triton + 1% BSA for 45 minutes at room temperature. We incubated cells 
with α-Pou5f1 antibody (Santa Cruz: SC-9081) at 1:100 dilution in blocking solution for 1.5 
hours at room temperature and then washed in blocking solution three times. Next, we 
incubated cells in α-rabbit secondary antibody coupled to GFP (Jackson ImmunoResearch: 
111-486-152) at a dilution of 1:1000 in blocking solution for 45 minutes. Finally, we 
thoroughly washed cells in blocking solution three times, and added vectashield containing 
DAPI (VWR: 101098-044) to each well.
Public Dataset curation
Traditionally, lineage markers are used to identify changes in phenotypic states. While these 
markers can be good indicators of differentiation potential, there are two major limitations 
with this approach. First, there are multiple genes that are associated with each lineage so 
simply looking at one can often be misleading. Second, this approach only works for 
classifying states with well-characterized marker genes but would not work for a 
comprehensive characterization of the function in the cell. Therefore, we decided to take a 
different approach and look at the entire gene expression profile of each lincRNA 
knockdown to determine what cell state each lincRNA resembles.
We curated a set of ES perturbations and differentiation states from publicly available 
sources. Specifically, we utilized the NCBI e-utils (http://eutils.ncbi.nlm.nih.gov/) to 
programmatically identify all published datasets containing keywords associated with 
embryonic stem cells. We filtered the list to only include mouse data sets that were 
generated across one of three commercial array platforms (Affymetrix, Agilent, and 
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Illumina). Following this approach, we manually curated the list to include datasets 
associated with ESC perturbations (genetic deletions, RNAi, or chemical perturbations) and 
differentiation or induced differentiation profiles. This curation yielded 41 GEO datasets 
corresponding to >150 samples.
Specifically, we defined differentiation lineage states using the following datasets.
1. Neuro-ectoderm. We downloaded a dataset (GSE12982) corresponding to mouse 
ES cells containing a Sox1-GFP reporter construct. Upon differentiation of Sox1-
GFP ES cells into Embryoid bodies (EBs), Sox1-GFP positive cells were collected 
and their global expression was profiled59. In addition, we downloaded a dataset 
(GSE4082)60 corresponding to direct neuroectoderm differentiation61.
2. Mesoderm. We downloaded the same dataset (GSE12982) as above, where the 
authors differentiated Brachyury-GFP reporter ES cells into EBs and sorted and 
profiled Brachyury-GFP positive cells59.
3. Endoderm. We downloaded a dataset (GSE11523) corresponding to mouse ES 
cells which were engineered to overexpress GATA633. GATA6 overexpression has 
been shown to drive ES cells into a primitive endoderm-like state62.
4. Ectoderm. We downloaded a dataset (GSE4082)60 corresponding to mouse ES 
cells differentiated into primitive ectoderm like cells with defined media61.
5. Trophectoderm. We downloaded a dataset (GSE11523)33 corresponding to mouse 
ES cells which were engineered to deplete Oct435. These cells have been shown to 
enter a trophectoderm-like state35. To ensure specificity to the trophectoderm state, 
we also compared the expression effects to trophoblast stem cells33. For all 
lincRNAs identified, we required a significant enrichment for both induced Oct4 
knock-out and trophoblast stem cell programs.
In addition, for all lineage states we utilized a curated discrete gene expression signature of 
differentiation which was previously functionally tested and shown to correspond 
specifically to differentiation into the associated states63.
Continuous enrichment analysis and Phenotype-projection analysis
To determine relationships between lincRNA knockdowns and functional states, we employ 
a modified Gene Set Enrichment Analysis34 approach that accounts for the continuous 
nature of the two datasets, similar to previously described extensions34,64,65. For each 
lincRNA knockdown by functional pair we compute a continuous enrichment score. 
Specifically, (i) for each lincRNA knockdown we compute a normalized score matrix 
compared to a panel of negative control hairpins by computing a t-statistic for each gene 
between the replicate lincRNA knockdown expression values and the control knockdown 
values. (ii) For each experiment, we sort the matrix by the normalized score such that the 
most differentially expressed upregulated gene is first and the most differentially expressed 
downregulated genes is last. Using this ordering we sort the functional dataset such that the 
ordering corresponds to the differential rank of the lincRNA knockdown set. (iii) We 
compute a score Si as the running average of values from the first position to position i. We 
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then define the enrichment score E as the maximum of the absolute value of Si for all values 
of i>10. We require i>10 to avoid small fluctuations in the beginning of the ranked list 
causing fluctuations in the enrichment score. This score is computed for each lincRNA 
knockdown by functional set. Since we have many lincRNA knockdowns and functional 
sets, in reality we have a matrix of scores and we will refer to the enrichment score of the ith 
knockdown and jth functional set as Eij.
To assess the significance of these scores, we compute a permutation derived false discovery 
rate and assign a confidence value for each projection. Specifically, to assess the 
significance of Eij, we permute the lincRNA knockdown samples and control samples and 
compute the enrichment score for each pair across all permutations. To account for the false 
discovery rate associated with many lincRNAs and functional sets, we use the values of all 
permutations directly to assess the FDR level of Eij. Specifically, to assess the FDR for each 
enrichment value Eij, we accumulate all the permutation values for all lincRNA knockdowns 
and functional sets and compute the number of values greater than Eij as well as a vector of 
values greater than Eij corresponding to each permutation. The FDR is computed as the 
average number of permuted values greater than Eij divided by the observed number greater 
than Eij. Using this approach, we assign an FDR value to each lincRNA knockdown by 
functional set and identify significant hits as those with an FDR<0.01.
To highlight the accuracy of this approach, we observed that for publicly available gene 
perturbations for which we also perturbed the gene we were able to identify a significant 
association of target genes in ~75% of cases. While the remaining few did not pass our 
conservative significance criteria, they also showed increased enrichments consistent with 
their common effects. In addition, the projected effects are highly reproducible across 
distinct experiments originating from many groups and across multiple expression 
platforms. Highlighting the specificity of this approach, we note that there are many profiles 
for which no lincRNA had a similar effect.
Analysis of gene-expression overlaps between independent hairpin knockdowns
To determine whether independent hairpins targeting the same lincRNA gene share common 
gene targets, we computed a continuous enrichment score described above. Briefly, we 
computed a t-statistic for both hairpins against the negative controls. We then took the 
second best hairpin and sorted the genes. We scored the best hairpin affected genes based on 
this ranked order. We assessed the significance of this enrichment by permuting the samples 
and controls and assigned an FDR of the overlap of the expression effect (as described 
above).
Discrete gene set analysis
Discrete gene sets were analysed using the Gene Set Enrichment Analysis with a slight 
modification to the scoring procedure to be more analogous to our continuous scoring 
procedure (described above). Specifically, we computed the average of the expression 
changes (defined by the t-statistic) for all genes within the discrete gene set upon 
knockdown63. Significance was assessed by permuting the control and sample labels and 
Guttman et al. Page 18
Nature. Author manuscript; available in PMC 2012 March 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
recomputing the average statistic for each permutation. The FDR was assessed off of these 
values as described above.
Lineage marker gene analysis
We curated lineage marker gene sets from published work and publicly available 
sources17,32,63. We identified lineage marker genes as significantly upregulated using the 
differential expression criteria outlined above. We validated the expression of these lineage 
marker genes for a selected set of lineage marker genes using qPCR (as described above) 
after a 4-day infection. Specifically, we looked at the expression of FGF5 (ectoderm), Sox1 
(neuroectoderm), Sox17 (endoderm), Brachyury (mesoderm), and Cdx2 (trophectoderm). 
Primer sequences are listed in Supplemental Table 9. Expression estimates were normalized 
to Gapdh and compared to a panel of 25 negative control hairpins.
Identifying bound lincRNA promoters
We obtained genome-wide transcription factor binding data in mouse ES cells from 2 
sources. The transcription factors Oct4, Sox2, Nanog, and Tcf3 were downloaded from the 
Gene Expression Omnibus (GSE11724) and the cMyc, nMyc, Zfx, Stat3, Smad1, Klf4, and 
Esrrb from GEO (GSE11431). For each ChIP-Seq dataset, the raw reads were obtained from 
the SRA (http://www.ncbi.nlm.nih.gov/sra) and processed as follows. (i) The reads were all 
aligned to the mouse genome assembly (build MM9) using the Bowtie aligner66, requiring a 
single best placement of each read. All reads with multiple acceptable placements were 
removed from the analysis. (ii) Binding sites were determined from the aligned reads using 
the MACS67 (http://liulab.dfci.harvard.edu/MACS/) algorithm using the default parameters 
with –mfold 8 to account for varying read counts in the libraries. (iii) lincRNA promoter 
regions were defined as previously described2,3 using the location of the K4me3 peaks 
overlapping or within 5Kb of the transcriptional start site determined by RNA-Seq 
reconstruction. (iv) The transcription factor binding locations and lincRNA promoter 
locations were intersected and the enrichment level of the peak overlapping a lincRNA 
promoter was assigned transcription factor binding enrichment for each lincRNA. We 
defined transcription factor binding locations for protein-coding genes in a comparable way. 
(v) To exclude the possibility that some of this binding might be due to transcription factor 
binding at distal enhancers, we excluded all binding events that showed evidence of P300, a 
protein associated with active enhancers68, localization. Altogether, we only identified ~5% 
of promoters overlapping with any P300 enrichment signal, a slightly lower percentage than 
identified for protein-coding gene promoters with detectable P300 signal.
Identifying TF-regulated lincRNA genes
lincRNA probes on the Agilent microarray were analysed using the differential expression 
methodology described above after knockdown of the transcription factor and comparison to 
the negative control hairpins. To confirm the expression changes of these lincRNAs, we 
hybridized 12 transcription factor knockdowns on a custom lincRNA codeset using the 
Nanostring nCounter assay41 (LIN-MES1-96). The knockdowns were profiled in biological 
duplicate along with 15 negative controls. Regulated lincRNAs were identified using the 
differential expression approach described above.
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Nanostring probeset design
Nanostring probes against lincRNA genes were designed following the standard nanostring 
design principles with the following modifications specifically for the lincRNA probes. (i) 
To exclude possible cross-hybridization, probes were screened for cross-hybridization 
against both the standard mouse transcriptome as well as a background database constructed 
from all the lincRNA sequences. (ii) To account for isoform coverage, a first pass design 
attempted to select a probe that would target as many isoforms as possible for each 
lincRNA. In cases where it was not possible to target all isoforms for a given lincRNA, the 
probe that targeted the largest number was selected, and additional probes were chosen 
when possible to target the remaining isoforms. (iii) The standard restrictions on Tm and 
sequence composition were relaxed to include probes for as many lincRNAs as possible.
Retinoic Acid differentiation
V6.5 cells were cultured on gelatin-coated dishes in mES media in the absence of LIF. 5μM 
of retinoic acid was added daily and cell samples were taken daily for 6 days. RNA was 
extracted using Qiagen’s RNeasy spin columns following the manufacturer’s protocol.
Western blots
30ug of mESC nuclear protein extracts were run on 10% Bis-Tris gels (Invitrogen 
NP0316BOX) in MOPS buffer (Invitrogen NP0001) at 75 volts for 20 minutes followed by 
120 volts for 1 hour. Gels were incubated for 30 minutes in 20% methanol transfer buffer 
(Invitrogen NP0006-1) and transferred onto PVDF membranes (Invitrogen 831605) at 20 
volts for 1 hour using the Bio-Rad semi-dry transfer system (170–3940). Membranes were 
blocked in Blotto (Pierce, 37530) at room temperature for 1 hour. Antibodies were diluted in 
Blotto and membranes were incubated overnight at 4°C. Antibodies were diluted in using 
the following concentrations. Ezh2 1:2000, Suz12 1:5000, hnRNPH 1:1000, Ruvbl2 1:1000, 
Jarid1b 1:500, HDAC1 1:250, Cbx6 1:500, YY1 1:500. All antibodies tested were raised in 
rabbit. The next day, membranes were washed 3x in 0.1% TBST for 5 minutes each. The 
membranes were probed with anti-Rabbit-horse radish peroxidase (GE Healthcare; 
NA9340V) at a 1:10,000 dilution, washed 3x in 0.1% TBST, incubated in ECL reagent (GE 
Healthcare RPN2132), and exposed.
Crosslinked RNA immunoprecipitation
V6.5 mES cells were fixed with 1% formaldehyde for 10 minutes at room temperature, 
quenched with 2.5M glycine, washed with 1x PBS (3x) harvested by scraping, pelleting, and 
resuspended in modified RIPA lysis buffer (150mM NaCl, 50mM Tris, 0.5% Sodium 
deoxycholate, 0.2% SDS, 1% NP-40) supplemented with RNase inhibitors (Ambion, 
AM2694) and protease inhibitors. For UV crosslinking experiments, cells were irradiated 
with 254nm UV light. Cells were kept on ice and crosslinked in 1x PBS using 400,000 
μjoules/cm2.
Cell suspension was sonicated using Branson 250 Sonifier for 3 × 20 s cycles at 20% 
amplitude. 10ul of Turbo DNase (Ambion, AM2238) was added to sonicated material, 
incubated at 37°C for 10 minutes, and spun down at max speed for 10 minutes at 4°C. 
Protein-G beads were washed and pre-incubated with antibodies for 30 minutes at room 
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temperature. Lysate and beads were incubated at 4°C for 2 hours. Beads were washed 3x 
using the following wash buffer (1x PBS, 0.1% SDS, 0.5% NP-40) followed by 2x using a 
high salt wash buffer (5x PBS, 0.1% SDS, 0.5% NP-40) and crosslinks were reversed and 
proteins were digested with 5ul proteinase-K (NEB, P8102S) at 65° for 2–4 hours. RNA was 
purified using phenol/chloroform/isoamyl alcohol and RNA was precipitated in isopropanol.
Nanostring hybridization
500ng of total RNA was hybridized for 17 hours using the lincRNA codeset. The hybridized 
material was loaded into the nCounter prep station followed by quantification on the 
nCounter Digital Analyzer following the manufacturer’s protocol. For RNA 
immunoprecipitation experiments, we used a modified protocol. After reverse crosslinking, 
RNA was extracted using phenol/chloroform and ethanol precipitation methods and 
resuspended in 10ul of H2O. 5ul of the eluted material was hybridized for 17 hours using the 
lincRNA codeset.
Nanostring analysis
Probe values were normalized to negative control probes by dividing the value of the probe 
by the maximum negative control probe. Probe values were floored to a normalized value of 
3 (3-fold higher than maximum negative control). Probes with no value greater than this 
floor across all samples were removed from the analysis. The values were log transformed. 
To control for variability between runs and different input material amounts, we normalized 
all samples simultaneously using the quantile normalization approach described above. The 
result is a set of normalized log-expression values for each probe normalized across all 
experiments.
Validation of RNA immunoprecipitation methods
To validate our formaldehyde based RNA immunoprecipitation method we 
immunoprecipitated the RNA binding protein hnRNPH, which plays a role in mRNA 
splicing69 and identified the associated RNAs. Consistent with known interactions, we 
identified a strong enrichment for its binding to intronic regions of mRNA genes. We 
validated these observed results in mouse ES cells by performing UV-crosslinking 
experiments70–72 and identified nearly identical results. We identified a similar correlation 
between the UV and formaldehyde crosslinked samples as for biological replicates of UV 
crosslinked samples and formaldehyde crosslinked samples and highly comparable 
enrichments (data not shown).
Antibody Selection
We selected chromatin proteins that have been implicated in regulation of the pluripotent 
state along with their known associated ‘reader’, ‘writer’, and ‘eraser’ complexes. 
Specifically, we tested antibodies against 40 chromatin proteins, corresponding to 28 
chromatin complexes. In many cases, we tested multiple antibodies against the same target 
protein to try and identify an antibody that worked well for immunoprecipitation. A full list 
of tested complexes and their associated antibodies are listed in Supplemental Table 18.
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Determining significant chromatin-lincRNA enrichments
We tested each antibody using formaldehyde crosslinked cells and had a two-step procedure 
for considering an antibody successful. (i) We tested all selected antibodies in batches, with 
each batch containing a mock-IGG (Santa Cruz) negative control and hnRNPH (Bethyl) 
positive control. Batches with variability in either the mock-IGG or hnRNPH controls were 
excluded and retested. For each successful batch, we computed enrichment for each 
lincRNA between the tested antibody and mock-IGG. We considered an antibody successful 
in the first step if the highest enrichment level exceeded a 5-fold change compared to the 
mock-IGG control and more than 10 lincRNAs exceeded this threshold. While this approach 
can yield false positives (antibodies that pass but are not efficient) it significantly reduced 
the number of antibodies to be tested in the next step. (ii) For all antibodies that successfully 
passed the first criteria, we performed immunoprecipitation on two additional biological 
replicates along with 4 mock-IGG controls. We computed a t-statistic for each lincRNA 
compared to the controls and assessed the significance using a permutation test, by 
permuting the samples and IGG samples (as above). Hits were considered significant if they 
exceed a t-statistic cutoff of 2 (log scale) compared to the controls and had an FDR<0.2. We 
allowed a slightly higher FDR cutoff since the number of permutations was far smaller 
yielding lower power to estimate the FDR. Only antibodies yielding significant lincRNAs 
were considered successful. In total, we identified 12 of the 28 complexes (55 antibodies) 
with at least one successful antibody.
Determining significant overlaps between lincRNA and chromatin protein knockdown 
effects
To determine the functional overlap between the lincRNA and the chromatin complexes it 
physically interacts with, we compared the effects on gene expression upon knockdown of 
the lincRNA and the associated protein complex. To do this, we utilized the gene expression 
profiles determined for each lincRNA knockdown and knockdowns of 9 of the 12 identified 
chromatin complexes for which we had good hairpins. We defined each interaction between 
a lincRNA and protein, and compute a continuous enrichment score, generated all 
permutations of the control hairpins and sample hairpins and assigned a false discovery rate 
to the scores (as described above). At an FDR<0.05 we identified 43% of the interactions to 
be significant. For 69% of the interactions, we were able to identify an overlap at an 
FDR<0.1.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Functional effects of lincRNAs
(a) A schematic of lincRNA perturbation experiments. ESCs are infected with shRNAs, 
knockdown level is computed, the best hairpin is selected and profiled on expression arrays, 
and differential gene expression is computed relative to negative control hairpins. (b) 
Example of a lincRNA knockdown. Top: Genomic locus containing the lincRNA. Bottom: 
Heatmap of the 95 genes affected by knockdown of the lincRNA, expression for control 
hairpins (red line) and expression for lincRNA hairpins (blue line) are shown. (c) 
Distribution of number of affected genes upon knockdown of 147 lincRNAs (blue) and 40 
well-known ESC regulatory proteins (red). Points corresponding to five specific ESC 
regulatory proteins are marked.
Guttman et al. Page 27
Nature. Author manuscript; available in PMC 2012 March 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. lincRNAs are critical for the maintenance of pluripotency
(a) Activity from a Nanog promoter driving luciferase, following treatment with control 
hairpins (black) or hairpins targeting luciferase (green), selected protein-coding regulators 
(red), and lincRNAs (blue). (b) Relative mRNA expression levels of Oct4 following 
knockdown of selected protein-coding (red) and lincRNA (blue) genes affecting Nanog–
luciferase levels. The best hairpin (black line) and second best hairpin (grey line) are shown. 
All knockdowns are significant with a p-value<0.01. Error bars represent standard error 
(n=4). (c) Morphology of ESCs and immunofluorescence staining of Oct4 for a negative 
control hairpin (black line), and hairpins targeting Oct4 (red line), and two lincRNAs (blue 
line). The first row shows bright field images, the second row shows immunofluorescence 
staining of the Oct4 protein, and the third row shows DAPI staining of the nuclei.
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Figure 3. lincRNAs repress specific differentiation lineages
(a) Expression changes for each lincRNA compared to gene expression of five 
differentiation patterns. Each box shows significant positive association (red, FDR<0.01) for 
Oct4 and Nanog (left) and for lincRNAs (right). (b) Expression changes upon knockdown of 
Oct4 and Nanog (black bars) and representative lincRNAs (grey bars) for five lineage 
marker genes. The expression changes (FDR<0.05) are displayed on a log scale as the t-
statistic compared to a panel of negative control hairpins.
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Figure 4. lincRNAs are direct regulatory targets of the ESC transcriptional circuitry
(a) A heatmap representing ChIP-Seq enrichments for 9 transcription factors (columns) at 
lincRNA promoters (rows). The percentage of bound lincRNAs downregulated upon knock-
down of the TF are indicated in boxes (‘na’ were not measured). Right: Examples of 
lincRNAs from two clusters (‘core regulated’ and ‘myc regulated’) showing their genomic 
neighbourhood and TF binding. (b) A heatmap representing changes in lincRNA expression 
(rows) following knockdown of 11 TFs (columns). Middle: Effect of knockdown of Sox2, 
Oct4 and Nanog on expression levels of linc1405 (gray) and Oct4 (black). Right: Effect of 
knockdown of Klf2, Klf4, nMyc, and Esrrb on expression levels of linc1428.
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Figure 5. lincRNAs physically interact with chromatin regulatory proteins
(a) A schematic of the classes of chromatin regulators profiled: ‘readers’ (blue), ‘writers’ 
(orange), and ‘erasers’ (green). (b) A heatmap showing the enrichment of 74 lincRNAs 
(rows) for one of 12 chromatin regulatory complexes (columns). The names are color-coded 
by chromatin-regulatory mechanism. Major clusters are indicated by vertical lines with a 
description of the chromatin components.
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Figure 6. A model for lincRNA integration into the molecular circuitry of the cell
ESC-specific transcription factors (such as Oct4, Sox2, and Nanog) bind to the promoter of 
a lincRNA gene and drive its transcription. The lincRNA binds to ubiquitous regulatory 
proteins, giving rise to cell-type specific RNA–protein complexes. Through different 
combinations of protein interactions, the lincRNA–protein complex can give rise to unique 
transcriptional programs. Right: A similar process may also work in other cell types with 
specific transcription factors regulating lincRNAs, creating cell-type–specific RNA–protein 
complexes and regulating cell-type–specific expression programs.
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